Pimodivir

N/A

Report date: 2025/04/28 22:35:30
NME

Base Information

Drug NamePimodivir
Drug Alias Name吡莫地韦JNJ-63623872JNJ-3872JNJ-872VX-787 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPolymerase basic protein 2 inhibitors
TargetsPolymerase basic protein 2
Therapy Area/IndicationsInfluenza A virus infectionsKidney Failure, ChronicHepatic Insufficiency +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[40] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesVertex Pharmaceuticals Incorporated
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJanssen-Cilag International NvJanssen Pharmaceuticals IncXian Janssen Pharmaceutical Ltd +[7] 
Active IndicationsN/A
Inactive IndicationsInfluenza A virus infectionsKidney Failure, ChronicHepatic Insufficiency +[4] 

Other Information

ATC CodeN/A
Related LinksN/A